Moreover, S100A8/S100A9 complex binds to endothelial cells via the S100A9 subunit interacting chiefly with heparin and heparan sulfate proteoglycans (125), contributing to the immobilization of the myeloid cell-derived S100A8/S100A9 complex on endothelium in human inflammatory diseases
Trx and GSH serve as electron-shuttles, transporting this reducing potential to various enzymes and reactions
J Cancer Ther 5(2):198-207, 2014
the compositions comprise about 0.05 %, about 0.1 %, about 0.2 %, about 0.3 %, about 0.4 %, about 0.5 %, about 0.6 %, about 0.7 %, about 0.8 %, about 0.9 %, about 1.0 %, about 1.1 %, about 1.2 %, about 1.3 %, about 1.4 %, about 1.5 %, about 1.6 %, about 1.7 %, about 1.8 %, about 1.9 %, about 2.0 %, about 2.1 %, about 2.2 %, about 2.3 %, about 2.4 %, about 2.5 %, about 2.6 %, about 2.7 %, about 2.8 %, about 2.9 %, about 3.0 %, about 3.1 %, about 3.2 %, about 3.3 %, about 3.4 %, about 3.5 %, about 3.6 %, about 3.7 %, about 3.8 %, about 3.9 %, about 4.0 %, the compositions comprise at least about 0.05 %, at least about 0.1 %, at least about 0.2 %, at least about 0.3 %, at least about 0.4 %, at least about 0.5 %, at least about 0.6 %, at least about 0.7 %, at least about 0.8 %, at least about 0.9 %, at least about 1.0 %, at least about 1.1 %, at least about 1.2 %, at least about 1.3 %, at least about 1.4 %, at least about 1.5 %, at least about 1.6 %, at least about 1.7 %, at least about 1.8 %, at least about 1.9 %, at least about 2.0 %, at least about 2.1 %, at least about 2.2 %, at least about 2.3 %, at least about 2.4 %, at least about 2.5 %, at least about 2.6 %, at least about 2.7 %, at least about 2.8 %, at least about 2.9 %, at least about 3.0 the compositions comprise about 0.005 % and about 5 % PP2 by weight of the composition
This product is not intended to treat, diagnose, cure or prevent any disease.
